Efficacy of PIMUN by Reducing Intermittent Hypoxia Events
Recruiting
N/A
Interventional Study
Preterm
Apnea of Prematurity
Hypoxemia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- Up to 30 Days
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 20 (estimated)
- Sponsor
- Pontificia Universidad Catolica de Chile · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if the use of PIMUN(medical device) works to reduce the intermittent hypoxemia of 24-34 weeks of birth gestational age babies. . It will also learn about the safety of the use of PIMUN. The main questions it aims to answer are:
Does PIMUN lower the time of oxygen saturation under 90%? What medical problems do participants have using PIMUN? Researchers w…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Preterm infants with a gestational age at birth \<34 weeks
* Age \<30 days at the time of enrollment
* Documented diagnosis of apnea of prematurity (AOP)
Exclusion Criteria:
* Currently receiving mechanical ventilation (MV)
* Presence of major congenital malformations
* Clin…
Contacts